-
1 Comment
Lifecome Biochemistry Co., Ltd is currently in a long term downtrend where the price is trading 10.5% below its 200 day moving average.
From a valuation standpoint, the stock is 36.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.1.
Lifecome Biochemistry Co., Ltd's total revenue sank by 19.3% to $67M since the same quarter in the previous year.
Its net income has dropped by 100.1% to $-29K since the same quarter in the previous year.
Finally, its free cash flow fell by 99.2% to $-78M since the same quarter in the previous year.
Based on the above factors, Lifecome Biochemistry Co., Ltd gets an overall score of 1/5.
| Industry | Biotechnology |
|---|---|
| Sector | Healthcare |
| ISIN | CNE100002QH2 |
| CurrencyCode | CNY |
| Exchange | SHE |
| Dividend Yield | 0.0% |
|---|---|
| Beta | 1.06 |
| Target Price | None |
| PE Ratio | None |
| Market Cap | 6B |
Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It primarily offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, natamycin products, etc. The company was founded in 2003 and is based in Pucheng, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002868.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
